AG
TECX

Artal Group’s Tectonic Therapeutic TECX Stock Holding History

Artal Group’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,954
Closed -$331K – 107
2019
Q3 		$331K Sell
1,954
-5,546
-74% -$1.26M 0.01% 102
2019
Q2 		$1.46M Sell
7,500
-833
-10% -$180K 0.06% 98
2019
Q1 		$2.21M Hold
8,333
– – 0.09% 94
2018
Q4 		$1.67M Hold
8,333
– – 0.06% 95
2018
Q3 		$5.19M Sell
8,333
-2,084
-20% -$924K 0.13% 74
2018
Q2 		$3.57M Buy
+10,417
New +$3.76M 0.08% 81

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group's TECX Position: Q4 2019 in Review

Artal Group sold out of Tectonic Therapeutic (TECX) in Q4 2019, closing a stake of 1,954 shares — an estimated $331K sold.

Artal Group first reported a position in TECX in Q2 2018 and held it in 6 quarters. The position peaked at $5.19M in Q3 2018. 89 funds tracked by Wall St. Rank hold TECX as of Q4 2019.

  • Artal Group reported no remaining Tectonic Therapeutic position as of Q4 2019 after selling out during the quarter.
  • Artal Group sold 1,954 Tectonic Therapeutic shares in Q4 2019, an estimated $331K.
  • Artal Group first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 6 quarters.
  • Artal Group's Tectonic Therapeutic position peaked at $5.19M in Q3 2018.
  • 89 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2019.

Based on Artal Group's 13F filing for Q4 2019, filed 13 Feb 2020.